{ "tag": [ "compiled" ], "id": "ocds-r6ebe6-0000574398-2019-06-04T00:00:00Z", "date": "2019-06-04T00:00:00Z", "ocid": "ocds-r6ebe6-0000574398", "initiationType": "tender", "parties": [ { "id": "org-19", "name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")", "identifier": { "legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")" }, "address": { "streetAddress": "Gyle Square (NSS Head Office), 1 South Gyle Crescent", "locality": "Edinburgh", "region": "UKM", "postalCode": "EH12 9EB" }, "contactPoint": { "name": "Iain Main- NDC Category Manager", "email": "nss.pcfndccategory@nhs.net", "telephone": "+44 1698794586", "url": "https://www.publictendersscotland.publiccontractsscotland.gov.uk" }, "roles": [ "buyer", "centralPurchasingBody", "reviewBody" ], "details": { "classifications": [ { "id": "Body governed by public law", "scheme": "TED_CA_TYPE" }, { "id": "07", "description": "Health", "scheme": "COFOG" }, { "id": "Regional or local authority", "scheme": "TED_CA_TYPE" } ], "url": "http://www.nhsscotlandprocurement.scot.nhs.uk/" } }, { "id": "org-1", "name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")", "identifier": { "legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")" }, "address": { "streetAddress": "Gyle Square (NSS Head Office), 1 South Gyle Crescent", "locality": "Edinburgh", "region": "UKM", "postalCode": "EH12 9EB" }, "contactPoint": { "name": "Alex Little", "email": "Alex.little1@nhs.net", "telephone": "+44 1698794410", "url": "http://" }, "roles": [ "buyer", "centralPurchasingBody", "reviewBody" ], "details": { "classifications": [ { "id": "Body governed by public law", "scheme": "TED_CA_TYPE" }, { "id": "07", "description": "Health", "scheme": "COFOG" } ], "url": "http://www.nhsscotlandprocurement.scot.nhs.uk/" } }, { "id": "org-227", "name": "AbbVie Ltd", "identifier": { "legalName": "AbbVie Ltd" }, "address": { "streetAddress": "Abbvie House, Vanwall Business Park", "locality": "Maidenhead", "region": "UK", "postalCode": "SL6 4UB" }, "contactPoint": { "telephone": "+44 7775116875" }, "roles": [ "supplier" ], "details": { "scale": "large", "url": "http://" } }, { "id": "org-228", "name": "Gilead Sciences Ltd", "identifier": { "legalName": "Gilead Sciences Ltd" }, "address": { "streetAddress": "280 High Holborn", "locality": "London", "region": "UK", "postalCode": "WC1V 7EE" }, "contactPoint": { "telephone": "+44 7747473021" }, "roles": [ "supplier" ], "details": { "scale": "large", "url": "http://" } }, { "id": "org-229", "name": "MSD", "identifier": { "legalName": "MSD" }, "address": { "streetAddress": "Hertford Road, Hoddesdon", "locality": "Herts", "region": "UK", "postalCode": "EN11 9BU" }, "contactPoint": { "telephone": "+44 1992455245" }, "roles": [ "supplier" ], "details": { "scale": "large", "url": "http://" } } ], "buyer": { "name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")", "id": "org-1" }, "tender": { "id": "NP49119", "title": "Hepatitis C Medicines", "description": "This procurement is for the supply of medicines used in the treatment of Hepatitis C to NHS Scotland. Pricing was requested under two (2) pricing models as outlined below: Lot 1 - Treatment Cost per Medicine Lot 2 - Treatment Spend Cap", "status": "complete", "items": [ { "id": "2", "additionalClassifications": [ { "id": "33600000", "scheme": "CPV" } ], "deliveryLocation": { "description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014." }, "deliveryAddresses": [ { "region": "UKM" }, { "region": "UKM" } ], "relatedLot": "2" }, { "id": "1", "additionalClassifications": [ { "id": "33600000", "scheme": "CPV" } ], "deliveryLocation": { "description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014." }, "deliveryAddresses": [ { "region": "UKM" }, { "region": "UKM" } ], "relatedLot": "1" } ], "value": { "amount": 45000000, "currency": "GBP" }, "procurementMethod": "open", "procurementMethodDetails": "Open procedure", "mainProcurementCategory": "goods", "submissionMethod": [ "electronicSubmission" ], "submissionMethodDetails": "https://www.publictendersscotland.publiccontractsscotland.gov.uk", "tenderPeriod": { "endDate": "2019-04-15T10:00:00Z" }, "awardPeriod": { "startDate": "2019-04-15T10:00:00Z" }, "documents": [ { "id": "MAR348518", "documentType": "contractNotice", "title": "Hepatitis C Medicines", "description": "This procurement is for the supply of medicines used in the treatment of Hepatitis C to NHS Scotland. Pricing will be requested under two (2) pricing models as outlined below: Lot 1 - Treatment Cost per Medicine Lot 2 - Treatment Spend Cap", "url": "https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=MAR348518", "format": "text/html" }, { "id": "JUN356232", "documentType": "awardNotice", "title": "Hepatitis C Medicines", "description": "This procurement is for the supply of medicines used in the treatment of Hepatitis C to NHS Scotland. Pricing was requested under two (2) pricing models as outlined below: Lot 1 - Treatment Cost per Medicine Lot 2 - Treatment Spend Cap", "url": "https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JUN356232", "format": "text/html" } ], "lots": [ { "id": "2", "title": "Treatment Spend Cap", "description": "This Framework Agreement is for the supply of branded medicines under a capped spend model used in the treatment of Hepatitis C to NHSScotland.", "status": "complete", "awardCriteria": { "criteria": [ { "type": "quality", "name": "Treatment Duration", "description": "2.5" }, { "type": "price", "description": "95" } ] }, "hasOptions": false, "submissionTerms": { "variantPolicy": "notAllowed" }, "contractPeriod": { "durationInDays": 660 }, "hasRenewal": true, "renewal": { "description": "The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twelve (12) months by giving a minimum of three (3) months written notice of such extension(s)." } }, { "id": "1", "title": "Treatment Cost per Medicine", "description": "This Framework Agreement is for the supply of medicines used in the treatment of Hepatitis C to NHSScotland.", "status": "complete", "awardCriteria": { "criteria": [ { "type": "quality", "name": "Treatment Duration", "description": "2.5" }, { "type": "price", "description": "95" } ] }, "hasOptions": false, "submissionTerms": { "variantPolicy": "allowed" }, "contractPeriod": { "durationInDays": 660 }, "hasRenewal": true, "renewal": { "description": "The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twelve (12) months by giving a minimum of three (3) months written notice of such extension(s)." } } ], "lotDetails": { "maximumLotsBidPerSupplier": 2147483647 }, "bidOpening": { "date": "2019-04-15T10:00:00Z" }, "communication": { "atypicalToolUrl": "https://www.publictendersscotland.publiccontractsscotland.gov.uk" }, "contractTerms": { "hasElectronicPayment": true, "hasElectronicOrdering": true, "electronicInvoicingPolicy": "allowed" }, "coveredBy": [ "GPA" ], "selectionCriteria": { "criteria": [ { "type": "suitability", "description": "Economic operators may be excluded from this competition if they are in breach of any situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015." }, { "type": "technical", "description": "(a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender. (b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent.", "minimum": "(a) Confirmation of existence of a current and valid UK Marketing Authorisation, or EMA Marketing Authorisation that has been approved by the MHRA, at the date of submission of the tender should be included in the Qualification Envelope of the ITT under the Technical and Professional ability: Quality Control for all tendered Medicines. (b) Confirmation of the existence of valid certification of BS EN ISO 9001 or equivalent. Confirmation of such certification should be included in the Qualification Envelope of the ITT under the Quality Assurance Schemes." } ] }, "submissionTerms": { "languages": [ "en" ], "bidValidityPeriod": { "durationInDays": 90 } }, "techniques": { "hasFrameworkAgreement": true }, "classification": { "id": "33600000", "scheme": "CPV" }, "reviewDetails": "The bringing of court proceedings against the Authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.", "hasRecurrence": false, "legalBasis": { "id": "32014L0024", "scheme": "CELEX" } }, "language": "EN", "description": "The estimated value range referred to in Sections II.I.5 and all Lots covers the twenty two (22) months initial duration and the maximum twelve (12) month extension period. (SC Ref:585089)", "links": [ { "rel": "canonical", "href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000574398" }, { "rel": "canonical", "href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000574398" } ], "noticetype": "OJEU - F3 - Contract Award Notice", "awards": [ { "id": "NP49119-1", "title": "Treatment Cost per Medicine", "suppliers": [ { "id": "org-227", "name": "AbbVie Ltd" }, { "id": "org-228", "name": "Gilead Sciences Ltd" }, { "id": "org-229", "name": "MSD" } ], "relatedLots": [ "1" ] }, { "id": "NP49119-2", "title": "Treatment Spend Cap", "suppliers": [ { "id": "org-227", "name": "AbbVie Ltd" }, { "id": "org-228", "name": "Gilead Sciences Ltd" } ], "relatedLots": [ "2" ] } ], "contracts": [ { "id": "NP49119-1", "awardID": "NP49119-1", "title": "Treatment Cost per Medicine", "status": "active", "value": { "amount": 9775000, "currency": "GBP" }, "dateSigned": "2019-05-08T00:00:00Z" }, { "id": "NP49119-2", "awardID": "NP49119-2", "title": "Treatment Spend Cap", "status": "active", "value": { "amount": 22808333, "currency": "GBP" }, "dateSigned": "2019-05-08T00:00:00Z" } ], "relatedProcesses": [ { "id": "1", "relationship": [ "planning" ], "scheme": "EU-OJ", "identifier": "2019/S 053-121476" } ], "bids": { "statistics": [ { "id": "386", "measure": "bids", "value": 3, "relatedLot": "1" }, { "id": "387", "measure": "bids", "value": 2, "relatedLot": "2" } ] } }